Vote Scores

Home / Companies / Bausch Health Companies Inc. / 19 May 2026

Meeting · year to 30 June 2026300 filers reporting

Bausch Health Companies Inc.: meeting of 19 May 2026

Votes reported on Form N-PX, item by item

300 Form N-PX filers reported votes at the Bausch Health Companies Inc. meeting of 19 May 2026. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

10 nominees; 96.6% of reported votes for; 10 filers withheld from or voted against at least one nominee.

591 vote records from 43 filers. 0 of the 42 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

100.0% for0.0% against0.0% against management43 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

391 vote records from 298 filers. 16 of the 281 filers that marked the item either way voted against management. 17 filers reported this item without a management mark.

88.3% for5.7% against6.0% other5.7% against management298 filers95.9% for3.9% against0.1% other3.9% against management205,861,447 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

59 vote records from 42 filers. 0 of the 41 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

100.0% for0.0% against0.0% against management42 filers100.0% for0.0% against0.0% against management18,645,372 reported shares

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
VanguardForForFor
BlackRock and iSharesForForFor
FidelityForForFor
DimensionalForForFor
State Street and SPDRForForFor
American CenturyForForFor
Franklin TempletonNo reportForNo report
InvescoForForFor
Charles SchwabForForFor
Nuveen and TIAAForAgainst *For
John Hancock and ManulifeForForFor
Morgan Stanley, Eaton Vance and CalvertNo reportForNo report
Goldman SachsNo reportForNo report
Northern Trust and FlexSharesForForFor
SEINo reportForNo report
T. Rowe PriceNo reportForNo report
ThriventForForFor
Lincoln FinancialForForFor
VoyaForForFor
First TrustNo reportForNo report
Russell InvestmentsNo reportForNo report
NationwideForForFor
Brighthouse FundsForForFor
BNY MellonNo reportForNo report
Federated HermesForForFor
AllianceBernsteinNo reportForNo report
PIMCOForForFor
Harbor FundsForForFor
VanEckForForFor
Neuberger BermanNo reportForNo report
Natixis and Loomis SaylesNo reportForNo report
BairdNo reportForNo report

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Bausch Health Companies Inc. meeting?

300 Form N-PX filers reported votes at the meeting of 19 May 2026. On say-on-pay, 16 of 281 voted against management (5.7%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Bausch Health Companies Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Bausch Health Companies Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Bausch Health Companies Inc. with a meeting date within three days of 19 May 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.